Found 368 results
Author [ Keyword(Desc)] Title Type Year
Filters: First Letter Of Last Name is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Histocompatibility Antigens Class I
Gazit E, Gothelf Y, Gil R, Orgad S, Pitman TB, Watson AL, Yang SY, Yunis EJ.  1984.  Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.. J Immunol. 132(1):165-9.
Histone Deacetylase Inhibitors
Myzak MC, W Dashwood M, Orner GA, Ho E, Dashwood RH.  2006.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.. FASEB J. 20(3):506-8.
Histones
Myzak MC, W Dashwood M, Orner GA, Ho E, Dashwood RH.  2006.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.. FASEB J. 20(3):506-8.
HLA Antigens
Gazit E, Gothelf Y, Gil R, Orgad S, Pitman TB, Watson AL, Yang SY, Yunis EJ.  1984.  Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.. J Immunol. 132(1):165-9.
Homozygote
Bredefeld C, M Hussain M, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ et al..  2022.  Guidance for the diagnosis and treatment of hypolipidemia disorders.. J Clin Lipidol. 16(6):797-812.
Humans
Gazit E, Gothelf Y, Gil R, Orgad S, Pitman TB, Watson AL, Yang SY, Yunis EJ.  1984.  Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.. J Immunol. 132(1):165-9.
Kopparapu PR, Pearce MC, Löhr CV, Duong C, Jang HSang, Tyavanagimatt S, O'Donnell EF, Nakshatri H, Kolluri SK.  2024.  Identification and Characterization of a Small Molecule Bcl-2 Functional Converter.. Cancer Res Commun. 4(3):634-644.
Maier MLVermilli, Siddens LK, Pennington JM, Uesugi SL, Tilton SC, Vertel EA, Anderson KA, Tidwell LG, Ognibene TJ, Turteltaub KW et al..  2023.  Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.. Toxicol Appl Pharmacol. 460:116377.
Bailey GS, Reddy AP, Pereira CB, Harttig U, Baird W, Spitsbergen JM, Hendricks JD, Orner GA, Williams DE, Swenberg JA.  2009.  Nonlinear cancer response at ultralow dose: a 40800-animal ED(001) tumor and biomarker study.. Chem Res Toxicol. 22(7):1264-76.
Neufeld LM, Ho E, Obeid R, Tzoulis C, Green M, Huber LG, Stout M, Griffiths JC.  2023.  Advancing nutrition science to meet evolving global health needs.. Eur J Nutr. 62(Suppl 1):1-16.
Bredefeld C, M Hussain M, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ et al..  2022.  Guidance for the diagnosis and treatment of hypolipidemia disorders.. J Clin Lipidol. 16(6):797-812.
Mastaloudis A, Yu T-W, O'Donnell RP, Frei B, Dashwood RH, Traber MG.  2004.  Endurance exercise results in DNA damage as detected by the comet assay.. Free Radic Biol Med. 36(8):966-75.
Orner GA, Dashwood W-M, Dashwood RH.  2004.  Tumor-suppressing effects of antioxidants from tea.. J Nutr. 134(11):3177S-3178S.
Atwell LL, Zhang Z, Mori M, Farris P, Vetto JT, Naik AM, Oh KY, Thuillier P, Ho E, Shannon J.  2015.  Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy.. Cancer Prev Res (Phila). 8(12):1184-1191.
Maier MLVermilli, Siddens LK, Pennington JM, Uesugi SL, Labut EM, Vertel EA, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ et al..  2023.  Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.. Chem Biol Interact. 382:110608.
Dashwood W-M, Orner GA, Dashwood RH.  2002.  Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.. Biochem Biophys Res Commun. 296(3):584-8.
Hummel JM, Madeen EP, Siddens LK, Uesugi SL, McQuistan T, Anderson KA, Turteltaub KW, Ognibene TJ, Bench G, Krueger SK et al..  2018.  Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.. Food Chem Toxicol. 115:136-147.
Maier MLVermilli, Siddens LK, Pennington JM, Uesugi SL, Anderson KA, Tidwell LG, Tilton SC, Ognibene TJ, Turteltaub KW, Smith JN et al..  2022.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [C]-BaP.. Environ Int. 159:107045.
Jump DB, Torres-Gonzalez M, L Olson K.  2011.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.. Biochem Pharmacol. 81(5):649-60.
Lee BY, Ordovás JM, Parks EJ, Anderson CAM, Barabási A-L, Clinton SK, de la Haye K, Duffy VB, Franks PW, Ginexi EM et al..  2022.  Research gaps and opportunities in precision nutrition: an NIH workshop report.. Am J Clin Nutr. 116(6):1877-1900.
Hydrogen Peroxide
Dashwood W-M, Orner GA, Dashwood RH.  2002.  Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.. Biochem Biophys Res Commun. 296(3):584-8.
Hypobetalipoproteinemias
Bredefeld C, M Hussain M, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ et al..  2022.  Guidance for the diagnosis and treatment of hypolipidemia disorders.. J Clin Lipidol. 16(6):797-812.
Hypoxanthine Phosphoribosyltransferase
Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD, Horio DT, Dashwood RH.  2001.  beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol.. Carcinogenesis. 22(2):315-20.
Imidazoles
Santana-Rios G, Orner GA, Amantana A, Provost C, Wu SY, Dashwood RH.  2001.  Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay.. Mutat Res. 495(1-2):61-74.
Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH.  2002.  Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).. Mutat Res. 506-507:121-7.

Pages